192 related articles for article (PubMed ID: 18577160)
1. Beyond insulin replacement: addressing the additional needs of the diabetes patient.
Dailey G
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():83-97. PubMed ID: 18577160
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight.
Bonora E
Int J Clin Pract Suppl; 2007 Aug; (154):19-28. PubMed ID: 17593274
[TBL] [Abstract][Full Text] [Related]
3. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors.
Mathieu C; Bollaerts K
Int J Clin Pract Suppl; 2007 Aug; (154):29-37. PubMed ID: 17593275
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay.
Niswender K
Diabetes Obes Metab; 2010 Apr; 12(4):267-87. PubMed ID: 20380648
[TBL] [Abstract][Full Text] [Related]
5. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
Kumar A
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
[TBL] [Abstract][Full Text] [Related]
6. What to add in with metformin in type 2 diabetes?
Petrie JR; Adler A; Vella S
QJM; 2011 Mar; 104(3):185-92. PubMed ID: 21156663
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in incretin-based therapies.
Russell-Jones D; Gough S
Clin Endocrinol (Oxf); 2012 Oct; 77(4):489-99. PubMed ID: 22804841
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of hyperglycemia.
Kulasa KM; Henry RR
Expert Opin Pharmacother; 2009 Oct; 10(15):2415-32. PubMed ID: 19743938
[TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of type 2 diabetes mellitus.
Israili ZH
Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
[TBL] [Abstract][Full Text] [Related]
10. Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.
Blonde L
Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S4-11. PubMed ID: 19952303
[TBL] [Abstract][Full Text] [Related]
11. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
Halimi S
Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.
Penfornis A; Borot S; Raccah D
Diabetes Metab; 2008 Feb; 34 Suppl 2():S78-90. PubMed ID: 18640590
[TBL] [Abstract][Full Text] [Related]
13. Incretin-based therapies in type 2 diabetes: a review of clinical results.
Bosi E; Lucotti P; Setola E; Monti L; Piatti PM
Diabetes Res Clin Pract; 2008 Dec; 82 Suppl 2():S102-7. PubMed ID: 19022515
[TBL] [Abstract][Full Text] [Related]
14. Clinical decisions. Management of type 2 diabetes.
Goldberg RB; Holman R; Drucker DJ
N Engl J Med; 2008 Jan; 358(3):293-7. PubMed ID: 18199869
[No Abstract] [Full Text] [Related]
15. Beyond glycemic control: treating the entire type 2 diabetes disorder.
Brunton S
Postgrad Med; 2009 Sep; 121(5):68-81. PubMed ID: 19820276
[TBL] [Abstract][Full Text] [Related]
16. Targeting type 2 diabetes.
Schwanstecher C; Schwanstecher M
Handb Exp Pharmacol; 2011; (203):1-33. PubMed ID: 21484565
[TBL] [Abstract][Full Text] [Related]
17. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk.
Peters AL
Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S20-7. PubMed ID: 19952300
[TBL] [Abstract][Full Text] [Related]
18. Which oral agent to use when metformin is no longer effective?
Bannon M
QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402
[No Abstract] [Full Text] [Related]
19. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
[TBL] [Abstract][Full Text] [Related]
20. Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
Chaudhuri A; Dandona P
Diabetes Obes Metab; 2011 Oct; 13(10):869-79. PubMed ID: 21569185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
